2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Kidney Chronic Graft Injury

55.58 - Renal transplantation improves parathyroid function but does not correct vitamin D deficiency

Presenter: Roberto, Marcén, Madrid, Spain
Authors: Marcén R., Jimenez-Alvaro S., Villacorta F., Fernández-Rodriguez A., Galeano C., Villafruela J., Teruel J., Burgos F., Quereda C.

RENAL TRANSPLANTATION IMPROVES PARATHYROID FUNCTION BUT DOES NOT CORRECT VITAMIN D DEFICIENCY

KIDNEY - CHRONIC GRAFT INJURY

R. Marcén, S. Jimenez-alvaro, F.J. Villacorta, A. Fernández-rodriguez, C. Galeano, J.J. Villafruela, J.L. Teruel, F.J. Burgos, C. Quereda
Nephrology, Hospital Ramón y Cajal, Madrid/SPAIN

Body: Introduction: Persistent hyperparathyroidism has been previously reported after renal transplantation. However, most of these studies are cross-sectional or have a short follow-up. Deficiency of vitamin D is also common in renal transplant recipients but there are few studies about the natural evolution of this disorder. The aims of the present study was to prospectively evaluate the calcium-phosphate metabolism parameters during 3 years after transplantation. Patients and methods: 182 renal transplant recipients with a functioning graft at 12 months were included in the study. Donor and recipient-related data at the time of transplantation as well as graft function and calcium-phosphate metabolism parameters including; serum calcium and phosphate, intact parathyroid hormone (iPTH), calcidiol (25OHD), calcitriol (1,25OHD) and tubular reabsorption of phosphorus (TRP) at 1,3,6,12,24 and 36 months were prospectively collected. Results: Data at 3, 12 and 36 months are expressed at the table 1:

Variable 3 months 12 months 36 months
Creatinine (mg/dL) 1.7±0.6 1.6±0.6 1.6±0.5
Calcium (mg/dL) 9.3±0.9 9.5±0.7 9.4±1.0
Calcium>10.2g/dL 10.2% 15.2% 12.8%
Phosphate (mg/dL) 2.8±0.5 3.0±0.6*** 3.1±0.7***
iPTH (pg/mL) 180±189 166±134* 152±131**
iPTH >150 pg/mL 43.2% 40.0% 24.7%
25OHD (ng/ml) 24.2±14.6 22.3±13.0 20.5±10.5*
25OHD<16 ng/mL 32.6% 34.0% 43.5%
1,25OHD (pg/mL) 28.6±28.4 31.8±21.9 40.8±27.2**
1,25OHD<20pg/mL 49.5% 36.8% 31.3%

*p<0.05;**p<0.01 and *** p<0.001 vs 3 months There was an increase in the serum phosphate levels from 3 to 12 and 36 months and a progressive decrease in the iPTH and 1,25OHD concentrations. In the univariate analysis, iPTH levels at 12 months were related with time on dialysis, iPTH at 1 month, serum creatinine, serum albumin and serum phosphate at 12 months. Only time on dialysis, iPTH at 1 month and serum creatinine remained in the multivariate analysis. Conclusions: Pre-transplant hyperparathyroidism improved after successful renal transplantation but after 3 years an important number of patients had high iPTH levels. Calcidiol levels kept low and unchanged through the length of the follow-up, and most patiens had vitamin D insufficiency or deficiency. Our data suggest that vitamin D3 supplements should be administrated soon after transplantation.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada